Author:
Brandt Inger,Lambeir Anne-Marie,Maes Marie-Berthe,Scharpé Simon,De Meester Ingrid
Reference91 articles.
1. Abbott, CA, Yu, DM, Woollatt, E, Sutherland, GR, McCaughan GW, Gorrell MD, 2000, Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem. 267: 6140–6150.
2. Ahmad S, Wang L, Ward PE, 1992, Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Ther. 260: 1257–1261.
3. Ahren B, 2003, Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep. 3: 365–372.
4. Ahren B, Gomis R, Standl E, Mills D, Schweizer A, 2004, Twelve-and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care. 27: 2874–2880.
5. Ahren B, Hughes TE, 2005, Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like Peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing Peptide in mice. Endocrinology. 146: 2055–2059.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献